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Introduction: Thrombotic thrombocytopenic purpura is a type of occlusive thrombotic microangiopathy that is not
specific to pregnancy but occurs with an increased frequency during it. Prognosis of thrombotic thrombocytopenic
purpura greatly depends on early diagnosis and treatment. As delivery does not generally cause resolution of
thrombotic thrombocytopenic purpura, pregnancy termination is not initially considered, especially under 34 weeks,
although it may be required under some conditions such as preeclampsia. Plasma therapy, including plasmapheresis,
and steroids are used for treatment. In the event of an unfavorable course leading to cardiopulmonary arrest,
effectiveness of cardiopulmonary resuscitation measures greatly depends on an early start of such measures. In
pregnant patients, not only rapid implementation of these measures is required, but a decision should also be taken
about the convenience of fetal delivery through a perimortem Cesarean section.
Case presentation: We report the case of thrombotic thrombocytopenic purpura in a 30-year-old primigravida white
woman in week 28 of pregnancy that had a rapidly deteriorating course leading to cardiopulmonary arrest and an
emergency perimortem Cesarean section resulting in fetal survival but maternal death. The patient was asymptomatic
at admission and such an unfavorable evolution was initially unexpected. Analytical findings were treated with fresh
frozen plasma and methylprednisolone but they did not improve. Plasmapheresis was considered but cardiac arrest
rapidly ensued.
Conclusions: Despite the low prevalence of thrombotic thrombocytopenic purpura, the finding in a pregnant woman
of the triad consisting of anemia, thrombocytopenia, and neurological changes should guide clinical diagnosis, and
should prompt measurement of the metalloprotease ADAMTS-13 in order to rule out or confirm diagnosis of
thrombotic thrombocytopenic purpura and evaluate the best therapeutic option. If cardiopulmonary arrest occurs in a
woman with a gestational age of more than 24 weeks, a perimortem Cesarean section is advised if the patient has not
recovered her pulse after the first four minutes.
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Thrombotic thrombocytopenic purpura (TTP) is, like
hemolytic uremic syndrome (HUS), a type of occlusive
thrombotic microangiopathy that is not specific to preg-
nancy, but occurs with an increased frequency during it
[1]. The low prevalence of the condition and its severity
increase the interest of reports on the outcome of diag-
nosed and treated cases, particularly during pregnancy.
We report a case of TTP in a pregnant woman that had
an unfavorable course, leading to cardiopulmonary
arrest.
Despite the low overall frequency of TTP, there are two
factors that have been related to its increased incidence rate
during pregnancy: a hypercoagulable state, particularly in
women with thrombophilia, and decreased levels of
metalloprotease ADAMTS-13. Metalloprotease ADAMTS-
13 is an enzyme responsible for binding to large multimers
of von Willebrand factor (vWF), converting them into
smaller molecules. These large vWF multimers may be
seen in serum from patients with TTP due to decreased
levels of ADAMTS-13, which causes an increased platelet
adhesion along with those vWF multimers, leading to se-
vere thrombocytopenia and microangiopathic hemolytic
anemia associated with side effects in vital organs [2-4].
The reduced plasma ADAMTS-13 activity in familial TTP
patients is usually a consequence of homozygous mutations
in both of the ADAMTS-13 alleles located at chromosome
9 [5]. In acquired idiopathic TTP patients ADAMTS-13
activity is severely reduced only during an initial episode or
later recurrences. Immunoglobulin G (IgG) autoantibodies
that inhibit plasma ADAMTS-13 activity can be detected
during acquired episodes in 44% to 94% of patients,
suggesting the presence of a transient, or intermittently
recurrent, defect of immune regulation [6].
Clinically, the triad of microangiopathic hemolytic
anemia with schistocytes and a negative Coombs’ test,
thrombocytopenia causing bleeding diathesis and fluctuat-
ing neurological changes is commonly seen in up to 75%
of patients [7].
Prognosis of TTP has improved in the past 30 years
with development of plasma replacement therapies
based on administration of fresh plasma. Other treat-
ments such as plasmapheresis (plasma exchange) help to
remove large multimers and anti-ADAMTS-13 anti-
bodies. These treatments achieve a satisfactory response
in 90% of patients with TTP, with healing rates up to
80% [2-4].
Case presentation
A 30-year-old primigravida Caucasian white woman in
week 28 of pregnancy was referred to the emergency room
of our hospital for dizziness in the past two days with nor-
mal blood pressure (BP) levels and episodes of diplopia,
dyslalia, and paresthesia in the hands and lips, associatedwith a fronto-occipital headache. Prior progress of her
pregnancy had been normal. The patient only reported
that two weeks before she had noticed mild petechial
lesions in her lower limbs, which she did not consider im-
portant, (she did not even report them at admission),
together with some asthenia and adynamia. The last la-
boratory tests at week 25 had found a hemoglobin (Hb)
level of 10.5g/dL and a hematocrit value of 30%. Hepatitis
B virus, hepatitis C virus and human immunodeficiency
virus test results were negative.
Upon arrival at our center, the patient was seen to have
a marked skin, mucosal pallor and a good general condi-
tion, and she was oriented and cooperative. No edema
was found. Her neurological examination was normal. She
had a blood pressure (BP) value of 145/65mmHg. An
ultrasound examination upon admission showed a fetus in
a transverse position, with adequate biometrics (estimated
weight, 1100g), and normal placenta and amniotic fluid.
Her cardiotocographic recording was normal and there
were no contractions.
Laboratory tests performed at admission found a
hemoglobin level of 5.2g/dL, a platelet count of 5000, and
a normal white blood cells (WBC) count. Her biochemical
test results were as follows: lactic dehydrogenase (LDH)
1398U/L (control 87 to 241U/L), alkaline phosphatase
237U/L (control 50 to 135), serum glutamic-oxalacetic
transaminase (S-GOT) 39U/L (control 15 to 37), serum
glutamic-pyruvic transaminase (S-GPT) 62U/L (control
30 to 65), total bilirubin 4.2mg/dL (control <1mg/dL), and
uric acid 4.7mg/dL (control 3.7 to 7.2). Her coagulation
and kidney function were normal. As a first measure,
transfusion was started of four units of a concentrate of
red blood cells and two units of plasma (450cc). The pa-
tient was then admitted to the intensive care unit based
on her laboratory findings, but without a clear diagnosis.
The patient maintained normal vital signs for eight
hours following admission. The results of her laboratory
tests after transfusion included: Hb 8g/dL, 21,000 plate-
lets, LDH 1211U/L, S-GOT 74U/L, S-GPT 51U/L, total
bilirubin 3.8mg/dL, and normal coagulation and kidney
function. In a peripheral blood smear, the hematologist
identified schistocytes (>8%) with an increased reticulo-
cyte count, and diagnosis of thrombotic thrombocytope-
nic purpura was therefore suspected.
On that same morning, treatment was started with
methylprednisolone, 60mg every 12 hours (2mg/kg/day)
and fresh frozen plasma (225cc) every 12 hours. After re-
peat plasma administration in the evening, hematological
control tests showed decreases in platelet count and he-
moglobin. Her renal function remained normal, without
proteinuria and her fluid balance was monitored.
Plasmapheresis was considered but, with no apparent
cause, at 22:30h the patient experienced progressive
breathlessness and moist rales that did not respond to
Figure 2 Autopsy: petechial lesions in the brain.
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ric team was notified of the situation, and sedation and
orotracheal intubation were concomitantly started. Exit
through the tube of the pink foam characteristic of lung
edema, hypoxia, and severe progressive bradycardia were
seen, and cardiopulmonary arrest finally occurred.
Advanced cardiopulmonary resuscitation (CPR) proce-
dures with chest compression and vasoactive drugs were
started at 22:42h, while the obstetric team, after assessing
the vital status of the fetus and because of the extreme se-
verity of the mother, in cardiopulmonary arrest, decided to
perform a perimortem emergency Cesarean section in the
bed of the intensive care unit while resuscitation maneu-
vers continued. At 22:50h, a live fetus weighing 1173g with
an Apgar score of 4 out of 6 was delivered by Cesarean
section.
Advanced CPR procedures were continued for 45 mi-
nutes, including three defibrillations for ventricular fibrilla-
tion, until the patient finally experienced electromechanical
dissociation and asystole, and she died at 23:37h.
Autopsy findings included acute lung edema, multiple
microthrombi, particularly in brain, heart, liver, pancreas
and kidneys, consistent with a diagnosis of thrombotic
thrombocytopenic purpura (Figures 1, 2).
Discussion
There are two well-differentiated aspects in the reported
case; on the one hand, the unfavorable course of TTP
during pregnancy and, on the other hand, the manage-
ment of cardiopulmonary arrest in a pregnant patient at
the start of the third term of pregnancy.
In the reported patient, diagnosis of TTP was consi-
dered based on the laboratory findings, suggesting both
hemolytic anemia and thrombocytopenia, which had not
been suspected by her physician at the start of the epi-
sodes of neurological impairment.
The reported series show that the occurrence of evidence
of microangiopathic hemolytic anemia, mild renal failure,
severe thrombocytopenia (<25,000 platelets/microliter),
and increased liver enzymes with an elevated LDH/GPT
ratio in a pregnant woman with fluctuating neurological
symptoms should suggest TTP as a first diagnostic hypo-Figure 1 Autopsy: petechial lesions.thesis, rather than other potential microangiopathic condi-
tions such as the HELLP syndrome [2-4].
When the patient was admitted to our hospital, the
HELLP syndrome was one of the suspected diagnoses,
but the patient only had a mild transaminase elevation
at baseline. The patient had no elevated blood pressure
levels at any time. On the other hand, unlike TTP, HUS
occurs in the puerperal period in 90% of cases, mainly
causes renal microangiopathy, and its most common
clinical presentation includes edema, high blood pres-
sure, hemorrhagic changes or severe renal failure, with
diarrhea being a common close history.
Various studies have demonstrated an increased ma-
ternal and perinatal survival in cases of recurrent TTP
as the result of regular monitoring. As patients have had
prior episodes, the risk of recurrence is known.
Once diagnosis of TTP is suspected in a pregnant pa-
tient, it should be confirmed, and the need for performing
treatment with plasma exchange or plasmapheresis to
avoid worsening of the condition should be established.
The benefit of a treatment protocol based on ADAMTS-
13 levels has been reported [8-11].
The reported cases of pregnant women with recurrent
or initial TTP show that measurement of the enzyme
ADAMTS-13 allows for selecting which patients are
amenable to medical treatment with corticosteroids and
which would benefit from administration of plasma or
plasmapheresis. As 20 to 50% of patients who survive
the first episode experience a relapse one month or even
years after the acute episode of TTP, some risk factors
for recurrence have been analyzed. In these patients, the
association of severe ADAMTS-13 deficiency and the
presence of anti-ADAMTS-13 autoantibodies have been
reported as the most negative prognostic markers at re-
mission, increasing the relative risk of TTP recurrence
by 3.6 times [12,13]. In order to prevent the recurrence
of TTP, ADAMTS-13 levels and anti-ADAMTS-13
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women with prior episodes. The use of the monoclonal
antibody rituximab has been successfully reported in re-
lapsing TTP patients as a therapeutic option [14].
The lack of an initial clear diagnosis and the sudden
progress of the clinical condition did not allow for meas-
urement of ADAMTS-13 levels in our case.
TTP is a condition with a high mortality rate whose
prognosis largely depends on early diagnosis and treatment.
As delivery does not generally cause resolution of TTP, it is
not routinely indicated, especially under 34 weeks,
although it may be required if TTP is associated with pre-
eclampsia [9]. We do not know if we would have been able
to achieve a better response to treatment with corticos-
teroids and plasma after fetus delivery in the reported case.
Our approach was initially conservative because of the risk
of prematurity associated to such a short gestational age
(28 weeks).
In the reported case, diagnosis was made six hours after
admission to our hospital, and treatment was started with
corticosteroids and plasma. After a slight initial improve-
ment, the patient evolved in only eight hours to a tragic,
irreversible condition that led to massive lung edema and
cardiac arrest.
Although management of cardiac arrest is always com-
plex, such complexity is much greater when this occurs
in a pregnant woman at the end of the second term or
during the third term of pregnancy because the life of
the fetus is also in danger. The effectiveness of cardio-
pulmonary resuscitation measures greatly depends on
their early implementation. In a pregnant patient, not
only rapid implementation of such measures is required,
but a decision should be taken about the convenience of
fetus delivery. In the case reported, the fetus was deli-
vered seven minutes after the start of cardiopulmonary
resuscitation maneuvers. Two of those seven minutes
were required for traveling to the intensive care unit,
four minutes to evaluate fetal well-being, confirm the
lack of maternal response to resuscitation maneuvers
and decide the conduct of the Cesarean section, and one
minute for fetal delivery. The convenience of achieving
fetal delivery in accordance to the ‘four-minute rule’ is
based on the need to prevent the irreversible damage to
fetal brain that may occur when placental blood flow is
stopped for longer than five minutes. If resuscitation ma-
neuvers fail to recover a maternal pulse in four minutes, a
perimortem Cesarean section is indicated [15,16]. Two
years later, the child of the reported patient is showing
normal cognitive development.
Conclusions
Despite the low prevalence of TTP, the finding in a preg-
nant woman of the triad consisting of anemia, throm-
bocytopenia, and neurological changes should promptmeasurement of the metalloprotease ADAMTS-13 in
order to rule out or confirm diagnosis of TTP and evaluate
the best therapeutic option. If cardiopulmonary arrest
occurs in a woman with a gestational age of more than
24 weeks, a perimortem Cesarean section is advised if the
patient has not recovered her pulse after the first four
minutes.
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